This new insulin might mean fewer injections and better blood sugar control — both up and down — for diabetes patients.

They’re developing new therapeutics and treatments for cancer patients, building artificial intelligence personas to maximize ...

Read more on the importance of stock picking in today's market, with two standout dividend stocks offering strong ...

Glucose Health (OTCMKTS:GLUC – Get Free Report) is one of 51 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its competitors? We will compare Glucose ...

Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with ...

A modified insulin that can prevent sudden drops in blood sugar has been demonstrated in laboratory experiments and animal ...

Abbott Laboratories ABT reported third-quarter 2024 adjusted earnings per share (EPS) of $1.21, which beat the Zacks ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Scientists have designed a new form of insulin that can automatically switch itself on and off depending on glucose levels in ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

This week's weather proves winter has officially arrived, which means many of us will (begrudgingly) be flicking the heating ...

Automated insulin delivery systems not only improved glycemic endpoints but also alleviated disease burden and enhanced ...